Skip to main content

Animations

MJFF Publications

2751 - 2760 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2021
  • 2022
  • 2023
  • 2023
  • 2020
  • 2025
  • 2022
  • 2024
  • Summary Details
    OPEN
    Title: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adk6191
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Gut mucosal cells transfer α-synuclein to the vagus nerve
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.172192
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.96.15_supplement.4286
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29251
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 5
  • Summary Details
    OPEN
    Title: An individualized tractography pipeline for the nucleus basalis of Meynert lateral tract
    Journal Name: Imaging Neuroscience
    Publisher: MIT Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1162/imag_a_00067
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer’s Disease (4738)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4738
    Citation Count: 6
  • Summary Details
    OPEN
    Title: GDNF overexpression in astrocytes enhances branching and partially preserves hippocampal function in an Alzheimer’s rat model
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-025-02881-4
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Preprint Highlight: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA- dependent STING signaling
    Journal Name: Molecular Biology of the Cell
    Publisher: American Society for Cell Biology (ASCB)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1091/mbc.p22-02-1003
    Citation Count: 0
  • Summary Details
    OPEN
    Title: GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29773
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.